Clal Biotechnology reported ILS44.7M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 384M 295M Mar/2025
aTyr Pharma USD 71M 63M Sep/2025
Bio Path USD 1000K 4M Mar/2025
Brainstorm Cell Therapeutics USD 10M 4M Mar/2025
Cara Therapeutics USD 28M 11M Dec/2024
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
Infinity Pharmaceuticals USD 19M 5M Jun/2023
RedHill Biopharma USD 12M 17M Jun/2024